Speech-Language Pathologists in Girard, PA Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Beatriz Marin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8110 Simit Ln, Girard, PA 16417 Phone: 814-882-0761 |
Kerry Marshall Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8300 Ridge Rd, Girard, PA 16417 Phone: 814-474-5521 |
Katherine Sawtelle Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8110 Simit Ln, Girard, PA 16417 Phone: 814-882-0761 |
 Bebe Marin Speech Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8110 Simit Ln, Girard, PA 16417 Phone: 814-474-5324 |
Miss Halley Marchese, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8300 Ridge Rd, Girard, PA 16417 Phone: 814-474-5521 |
News Archive
New guidelines for managing chronic kidney disease in patients living with HIV infection
The HIV Medicine Association has released guidelines for managing chronic kidney disease in patients living with HIV infection. They are published in the June 1 issue of Clinical Infectious Diseases.
Best approach to removing a diseased thyroid may be from under the arm
The best approach to removing a diseased thyroid, the endocrine gland just under the Adam's apple that controls the body's metabolic rate, amazingly may be from under the arm, according to a study published in the August issue of the journal Laryngoscope.
PTR-TOF 1000 ultra – 2020 performance boost and new X2 option
2020 starts with a considerable performance upgrade of the PTR-TOF 1000 ultra. New and improved hardware components increase the instrument's sensitivity dramatically. Moreover, the PTR-TOF 1000 series now also features a higher mass resolution of > 2,000.
WHO says smoking bans work and benefit everyone
A report by the World Health Organisation (WHO) has confirmed the effectiveness of smoking bans and their benefit for everyone.
La Jolla Pharmaceutical announces $16.3 million private placement
La Jolla Pharmaceutical Company announced today that the Company has entered into definitive agreements with institutional investors and affiliates for a private placement of common stock, convertible preferred stock and warrants to purchase convertible preferred stock totaling up to $16.3 million in gross proceeds.
› Verified 5 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Chiropractors